SG Americas Securities’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $101K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $193K | Buy |
|
|||||
|
2024
Q4 | $181K | Buy |
|
|||||
|
2024
Q3 | $128K | Sell |
|
|||||
|
2024
Q2 | $1.38M | Sell |
|
|||||
|
2024
Q1 | $1.88M | Buy |
|
|||||
|
2023
Q4 | $2.21M | Sell |
|
|||||
|
2023
Q3 | $2.18M | Buy |
|
|||||
|
2023
Q2 | $1.56M | Buy |
|
|||||
|
2023
Q1 | $326K | Buy |
|
|||||
|
2022
Q4 | $173K | Sell |
|
|||||
|
2022
Q3 | $276K | Buy |
|
|||||
|
2022
Q2 | $160K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $240K | Sell |
|
|||||
|
2021
Q3 | $288K | Buy |
|
|||||
|
2021
Q2 | $117K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $750K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $349K | Sell |
|
|||||
|
2020
Q1 | $651K | Buy |
|
|||||
|
2019
Q4 | $156K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $156K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $130K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $310K | Buy |
|
|||||
|
2017
Q2 | $236K | Buy |
|
|||||
|
2017
Q1 | $202K | Sell |
|
|||||
|
2016
Q4 | $686K | Buy |
|